Cleared Traditional

K240364 - RELIEEV Uterine Manipulator Injector (CUMI 5.0) (FDA 510(k) Clearance)

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K240364 · Li Medical Corporation , Ltd. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2024
Decision
253d
Days
Class 2
Risk

K240364 is an FDA 510(k) clearance for the RELIEEV Uterine Manipulator Injector (CUMI 5.0). Classified as Cannula, Manipulator/injector, Uterine (product code LKF), Class II - Special Controls.

Submitted by Li Medical Corporation , Ltd. (Xizhi Dist., TW). The FDA issued a Cleared decision on October 16, 2024 after a review of 253 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.4530 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Li Medical Corporation , Ltd. devices

Submission Details

510(k) Number K240364 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 2024
Decision Date October 16, 2024
Days to Decision 253 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
93d slower than avg
Panel avg: 160d · This submission: 253d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LKF Cannula, Manipulator/injector, Uterine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.4530
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - LKF Cannula, Manipulator/injector, Uterine

All 86
Devices cleared under the same product code (LKF) and FDA review panel - the closest regulatory comparables to K240364.
FemVue® Controlled Saline-Air Device (FSA-300)
K253403 · Femasys, Inc. · Dec 2025
RELIEEV HSG Catheter (HSG7FA1)
K252260 · Li Medical Corporation , Ltd. · Nov 2025
FemVue MINI Saline-Air Device
K242002 · Femasys, Inc. · Nov 2024
FemChec Controlled Saline-Air Device (FCD-250)
K241693 · Femasys, Inc. · Sep 2024
Rejoni Intrauterine Catheter
K222798 · Rejoni, Inc. · Dec 2022
ALLY II Uterine Positioning System™ (UPS)
K223064 · CooperSurgical, Inc. · Oct 2022